Sequenom, a US-based manufacturer of DNA massarrays, has announced the submission of premarket 510(k) notifications to the US Food and Drug Administration (FDA) for its IMPACT Dx system and the IMPACT Dx Factor V Leiden and Factor II ...
Tags: Impact DX System, Sequenom